IDNA

iShares Genomics Immunology and Healthcare ETF
*Unless otherwise stated, data provided by FactSet.

IDNA Fund Description

The iShares Genomics Immunology and Healthcare ETF tracks a market-cap selected and weighted index of global stocks involved in genomics, immunology, and bioengineering.

IDNA Factset Analytics Insight

IDNA is a fund focused on global companies in the biopharmaceutical and healthcare equipment and services industries that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. Some included specific sectors are biopharmaceutical industries, healthcare equipment industries, and healthcare services industries. Potential constituents are scored based on revenue generated by the above relevant industries. IDNA selects the 50 top scoring equities, and does not limit its market cap size.

IDNA MSCI ESG Analytics Insight

iShares Genomics Immunology and Healthcare ETF has an MSCI ESG Fund Rating of BB based on a score of 3.33 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares Genomics Immunology and Healthcare ETF ranks in the 12nd percentile within its peer group and in the 20th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IDNA Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 03/26/20] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IDNA -10.00% -12.84% -10.57% -- -- -- --
IDNA (NAV) -10.28% -12.94% -10.81% -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IDNA Summary Data

Blackrock
iShares
06/11/19
Open-Ended Fund
0.47%
$22.95M
$564.68K
0.21%

IDNA Portfolio Data

$18.23B
-20.37
3.79
--
03/25/20
48

IDNA Index Data

NYSE FactSet Global Genomics and Immuno Biopharma Index
Market Value
Market Value
N/A

IDNA Portfolio Management

0.47%
--
--
--

IDNA Tax Exposures

20.00% / 39.60%
0.97%
Qualified dividends
No

IDNA Fund Structure

Open-Ended Fund
No
No
72% / 29%
N/A
N/A
High
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

IDNA Factset Analytics Block Liquidity

As of 03/27/20
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IDNA. IDNA is rated a 4 out of 5.

IDNA Tradability

21,354
$564.68K
8,750
$260.74K
0.21%
$0.06
0.19%
0.81% / -0.60%
None
--
50,000
0.17
0.07%
0.13%
12
$26.61
4

IDNA Sector/Industry Breakdown


IDNA
Segment Benchmark
73.93%
--
24.93%
--
1.13%
--

IDNA Top 10 Holdings[View All]

4.42%
4.25%
4.07%
48%

IDNA Countries


IDNA
Segment Benchmark
71.08%
--
11.32%
--
8.90%
--
4.50%
--
4.20%
--

IDNA Regions


IDNA
Segment Benchmark
71.08%
--
17.60%
--
11.32%
--

IDNA Economic Development


IDNA
Segment Benchmark
100.00%
--

IDNA Performance Statistics

--
--
--
--
0.00%
N/A

IDNA MSCI ESG Ratings

3.33 / 10
20.00
11.58
0.51%
13.29%
24.28

IDNA Benchmark Comparison Holdings

48
--
--
0.00%

IDNA Benchmark Comparison Summary


IDNA
Segment Benchmark
48
--
$18.23B
--
-20.37
--
3.79
--
0.66%
--
Medium
High

IDNA Benchmark Comparison Market Cap Size


IDNA
Segment Benchmark
34.47%
--
41.12%
--
20.02%
--
4.39%
--